William F. Peacock, MD

Articles by William F. Peacock, MD

Future Directions in the Treatment of Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

August 11th 2022

A panel of experts discuss their key takeaways and the future of treating opioid-induced constipation.

Collaboration Among Specialists in the Management of Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

August 11th 2022

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, discuss a multidisciplinary approach to treating patients with opioid-induced constipation.

Increasing Awareness Regarding Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

August 4th 2022

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, share their thoughts on how to bring awareness to opioid-induced constipation.

Management of Adverse Effects When Using PAMORAs for Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

August 4th 2022

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, discuss managing adverse events that stem from using peripheral μ-opioid receptor antagonists to treat opioid-induced constipation.

Optimizing Treatment Selection Between Oral and Subcutaneous PAMORAs

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

July 28th 2022

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, consider potential patient preferences when choosing oral vs subcutaneous peripheral μ-opioid receptor antagonists.

Reviewing Different PAMORAs for Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

July 28th 2022

A multidisciplinary panel shares individual experience with using oral peripherally acting μ-opioid receptor antagonists in managing opioid-induced constipation.

The Role of Mu-Opioid Receptor Agonists in the Management of Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

July 21st 2022

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, review the rationale for the use of μ-opioid receptor agonists for the treatment of opioid-induced constipation.

Transitioning Therapies for Patients With Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

July 21st 2022

Experts in gastroenterology review the challenges associated with switching therapies during inpatient and outpatient care for patients with opioid-induced constipation.

Selecting Optimal First-Line Treatments for Patients With Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

July 14th 2022

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, discuss the multidisciplinary approaches to selecting therapies for patients with opioid-induced constipation.

Approaches to Care in Patients with Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

July 14th 2022

A multidisciplinary panel shares practical approaches to treating patients with opioid-induced constipation and challenges with patient communication.

The Role of Specialty Pharmacies in the Management of Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

July 7th 2022

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, reviews the position of pharmacies in providing patients with opioid-induced constipation with the necessary medication to decrease hospitalization and cost of medication.

The Impact of Opioid-Induced Constipation on Patient Quality of Life

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

July 7th 2022

Experts in gastroenterology discuss the quality of life and perspective of patients with opioid-induced constipation.

Education and Identification of Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

June 30th 2022

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, explore the importance of early intervention and the overall challenges of ensuring that patients receive appropriate care for opioid-induced constipation.

Overview of Opioid-Induced Constipation

ByWilliam F. Peacock, MD,Conar Fitton, MD,Neel Mehta, MD

June 30th 2022

A multidisciplinary panel discusses the presentation, frequency, and burden of opioid-induced constipation.

Key Takeaways for OIC Management

ByWilliam F. Peacock, MD

June 17th 2022

Dr William F. Peacock shares clinical pearls for the management of opioid-induced constipation.

OIC Clinical Trial Patient Population and Study Design Considerations

ByWilliam F. Peacock, MD

June 17th 2022

An expert in emergency medicine shares his thoughts on the patient population inclusion criteria study designs when investigating treatment efficacy in patients with opioid-induced constipation.

Real-world Implications and Unmet Needs of OIC Management

ByWilliam F. Peacock, MD

June 17th 2022

William F. Peacock, MD, discusses real-world implications with opioid-induced constipation and comments on unmet needs in treating patients.

Economic Burden of OIC Management

ByWilliam F. Peacock, MD

June 10th 2022

Dr William F. Peacock provides insight on the economic burden of opioid-induced constipation management strategies, highlighting the impact of hospitalization rates and prescription costs.

Concomitant Drug Interactions and Adverse Events With Methylnaltrexone

ByWilliam F. Peacock, MD

June 10th 2022

An expert in emergency medicine comments on the adverse event profile and concomitant use considerations with the administration of methylnaltrexone in patients suffering from opioid-induced constipation.

Post Hoc Analysis of Single-Dose Methylnaltrexone Efficacy in OIC

ByWilliam F. Peacock, MD

June 3rd 2022

Dr William F. Peacock reviews key highlights and clinical implications from the post hoc analysis of a single dose of methylnaltrexone in patients suffering from opioid-induced constipation.